Yogaprol 25 Tablet ER
Marketer
HiGlance Laboratories
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Yogaprol 25 Tablet ER
Betapace ER 25mg tablets, a beta-blocker medication, effectively manages hypertension, angina pectoris, and cardiac arrhythmias. This medication also contributes to migraine prevention and reduces the risk of future strokes and myocardial infarctions. Dosage and administration frequency are tailored to individual needs and condition severity; it can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefit may take several weeks to manifest, and continuous use, even during symptom remission, is often necessary for long-term health management. Discontinuing treatment can exacerbate underlying conditions. Common, typically mild and transient, adverse effects include fatigue, cephalgia, depressive symptoms, diarrhea, dermatological reactions, bradycardia, vertigo, and nausea. Less frequent side effects encompass dyspnea and hypotension. Gradual dosage escalation, initiated at a low dose, minimizes adverse event risk. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, inform your doctor of any hepatic impairment, as this medication may be contraindicated in patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals require medical consultation before use. Individual suitability should be assessed by a healthcare professional, and regular blood pressure monitoring is essential to evaluate treatment efficacy. Alcohol consumption should be limited due to potential exacerbation of certain side effects.
Uses of Yogaprol 25 Tablet ER
Managing angina pectoris (chest pain stemming from heart issues)|Correcting cardiac arrhythmias|Cardiovascular event prophylaxis|Hypertension (high blood pressure) management|Migraine prevention
Major Benefits of Yogaprol 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Yogaprol 25 Tablet ER whole; do not chew, crush, or break it. This medication can be taken with or without food, but consistency in timing is recommended. For optimal absorption, it's advisable to avoid consuming Yogaprol 25 Tablet ER with meals high in fat, including those containing olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and red meat.
Common Side effects of Yogaprol 25 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Yogaprol 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Yogaprol 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended. Minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and meat while taking Yogaprol 25 Tablet ER.
How Yogaprol 25 Tablet ER works:
CardioBeta 25 Extended-Release tablets are a sustained-action beta-adrenergic receptor antagonist targeting cardiac function. They reduce heart rate and enhance the heart's efficiency in circulating blood throughout the body.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Yogaprol 25 Tablet ER.
PregnancyCONSULT YOUR DOCTOR
The use of Yogaprol 25 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingSAFE IF PRESCRIBED
Extended-release Yogaprol 25 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Yogaprol 25 mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Yogaprol 25 tablets are considered safe for use in individuals with kidney impairment. No alteration of the Yogaprol 25 Tablet ER dosage is necessary.
LiverCAUTION
Patients with liver impairment should exercise caution when using Yogaprol 25 Extended-Release tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Yogaprol 25 Tablet ER :
Should you forget to take a Yogaprol 25 Tablet ER, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Yogaprol 25 Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Type of Therapy | Heart |



